Jaguar Converts Preferred Stock
Jaguar converts Series O Convertible Preferred Stock into common stock on June 25th, 2026
209 shares of Jaguar voting common stock; no action by Preferred Stock holders is required. 68 per-share price, the closing price on June 24th, 2026. - Special Stock Dividend: Preferred Stock was issued as a one-time special stock dividend declared Feb. 18th, 2026, for record holders on March 2nd, 2026.
- Crofelemer program update: Two crofelemer presentations in pediatric intestinal failure patients with MVID and SBS-IF are set for the June 2026 ESPGHAN Annual Meeting. - CEO Lisa Conte says Jaguar is targeting Breakthrough Therapy designation for crofelemer for MVID, with a planned FDA NDA filing in the first half of 2027.